Sign in

CIK 0001498382

  • Non-accelerated filer
  • Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
990360497
Phone
+1 813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
  1. 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $1.30 ($13,000)
  2. 4 Open-market buy Chief Scientific Officer bought 5,000 shares at $1.56 ($7,808)
  3. 4 Open-market buy CEO and PRESIDENT bought 5,000 shares at $1.00 ($5,000)
  4. 4 Open-market buy CEO and PRESIDENT bought 5,000 shares at $0.80 ($4,000)
  5. 4 Open-market buy Director bought 9,000 shares at $0.83 ($7,504)
  6. 4 Open-market buy Director bought 9,000 shares at $0.88 ($7,920)
  7. 4 Open-market buy Director bought 2,000 shares at $0.87 ($1,740)
  8. 4 Open-market buy Director bought 7,500 shares at $0.91 ($6,825)
  9. 4 Conversion Director acquired 5,000 shares (conversion)
  10. 4 Open-market buy Director bought 5,000 shares at $1.00 ($5,000)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Conversion Director acquired 10,000 shares (conversion)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Conversion CEO and President acquired 22,000 shares (conversion)
  18. 4 Conversion Chief Scientific Officer acquired 34,000 shares (conversion)
  19. 3/A Insider 3/A
  20. 3/A Insider 3/A

Page 15 of 16 · 308 filings